Takeshi Osonoi

4.0k total citations
75 papers, 1.5k citations indexed

About

Takeshi Osonoi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Takeshi Osonoi has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 19 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Takeshi Osonoi's work include Diabetes Treatment and Management (32 papers), Diabetes Management and Research (20 papers) and Metabolism, Diabetes, and Cancer (14 papers). Takeshi Osonoi is often cited by papers focused on Diabetes Treatment and Management (32 papers), Diabetes Management and Research (20 papers) and Metabolism, Diabetes, and Cancer (14 papers). Takeshi Osonoi collaborates with scholars based in Japan, United States and Denmark. Takeshi Osonoi's co-authors include Naoto Katakami, Yasuo Terauchi, Iichiro Shimomura, Miyoko Saito, Hirotaka Watada, Masahiko Gosho, Tomoya Mita, Atsuko Tamasawa, Yusuke Osonoi and Taka‐aki Matsuoka and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Takeshi Osonoi

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Osonoi Japan 22 840 376 322 321 205 75 1.5k
Domenico Cozzolino Italy 23 439 0.5× 413 1.1× 361 1.1× 283 0.9× 248 1.2× 71 1.6k
Hidenori Yoshii Japan 16 627 0.7× 323 0.9× 217 0.7× 247 0.8× 203 1.0× 41 1.1k
Caterina Mammi Italy 24 755 0.9× 350 0.9× 271 0.8× 272 0.8× 194 0.9× 60 2.0k
Muxun Zhang China 21 705 0.8× 416 1.1× 343 1.1× 278 0.9× 400 2.0× 39 1.6k
Shojiro Sawada Japan 25 513 0.6× 665 1.8× 350 1.1× 681 2.1× 413 2.0× 63 2.1k
Ya‐Hui Hu China 23 416 0.5× 445 1.2× 153 0.5× 402 1.3× 105 0.5× 107 1.7k
Salim Thabet United States 9 452 0.5× 274 0.7× 548 1.7× 130 0.4× 135 0.7× 12 1.7k
Takuhito Shoji Japan 20 408 0.5× 214 0.6× 388 1.2× 137 0.4× 230 1.1× 39 1.5k
Gang Yuan China 17 658 0.8× 268 0.7× 332 1.0× 157 0.5× 355 1.7× 40 1.4k
Brent A. McLean Canada 16 570 0.7× 513 1.4× 460 1.4× 466 1.5× 122 0.6× 24 1.6k

Countries citing papers authored by Takeshi Osonoi

Since Specialization
Citations

This map shows the geographic impact of Takeshi Osonoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Osonoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Osonoi more than expected).

Fields of papers citing papers by Takeshi Osonoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Osonoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Osonoi. The network helps show where Takeshi Osonoi may publish in the future.

Co-authorship network of co-authors of Takeshi Osonoi

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Osonoi. A scholar is included among the top collaborators of Takeshi Osonoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Osonoi. Takeshi Osonoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agarwal, Rajiv, Jennifer B. Green, Hiddo J.L. Heerspink, et al.. (2025). Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia. Clinical Journal of the American Society of Nephrology. 21(1). 72–82.
2.
3.
4.
Mita, Tomoya, Naoto Katakami, Yosuke Okada, et al.. (2021). Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes. BMJ Open Diabetes Research & Care. 9(1). e001923–e001923. 30 indexed citations
5.
Mita, Tomoya, Naoto Katakami, Yosuke Okada, et al.. (2021). Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes. Cardiovascular Diabetology. 20(1). 15–15. 39 indexed citations
6.
Osonoi, Takeshi, et al.. (2020). Liraglutide Improves Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Kidney Disease and Type 2 Diabetes: A 7-Year Retrospective Analysis. Diabetes Technology & Therapeutics. 22(11). 828–834. 8 indexed citations
7.
Kashihara, Naoki, Yoshimitsu Yamasaki, Takeshi Osonoi, et al.. (2020). A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia. Clinical and Experimental Nephrology. 25(2). 140–149. 12 indexed citations
8.
Mita, Tomoya, Yuki Someya, Yusuke Osonoi, et al.. (2020). Lower intake of saturated fatty acids is associated with persistently higher arterial stiffness in patients with type 2 diabetes. Journal of Diabetes Investigation. 12(2). 226–233. 3 indexed citations
9.
Katakami, Naoto, Tomoya Mita, Masahiko Gosho, et al.. (2018). Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies. Journal of Atherosclerosis and Thrombosis. 25(10). 1053–1066. 34 indexed citations
10.
Osonoi, Takeshi, et al.. (2018). Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study. Diabetes Technology & Therapeutics. 20(10). 681–688. 20 indexed citations
11.
Yagihashi, Soroku, et al.. (2016). Four‐year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetes. Journal of Diabetes Investigation. 8(3). 369–376. 9 indexed citations
12.
Katakami, Naoto, Takeshi Osonoi, Mitsuyoshi Takahara, et al.. (2015). Association between new onset diabetic retinopathy and monocyte chemoattractant protein-1 (MCP-1) polymorphism in Japanese type 2 diabetes. Diabetes Research and Clinical Practice. 108(3). e35–e37. 12 indexed citations
13.
Osonoi, Takeshi, Miyoko Saito, Atsuko Tamasawa, Hidenori Ishida, & Yusuke Osonoi. (2014). Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study. Expert Opinion on Pharmacotherapy. 15(10). 1325–1335. 8 indexed citations
14.
Mochizuki, Kazuki, Seiya Inoue, Miyoko Saito, et al.. (2014). Switching α-Glucosidase Inhibitors to Miglitol Reduced Glucose Fluctuations and Circulating Cardiovascular Disease Risk Factors in Type 2 Diabetic Japanese Patients. Drugs in R&D. 14(3). 177–184. 8 indexed citations
15.
16.
Katakami, Naoto, Takeshi Osonoi, Mitsuyoshi Takahara, et al.. (2014). Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients. Cardiovascular Diabetology. 13(1). 128–128. 61 indexed citations
17.
Katakami, Naoto, Hideaki Kaneto, Taka‐aki Matsuoka, et al.. (2011). Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes. Atherosclerosis. 220(2). 437–442. 23 indexed citations
18.
Katakami, Naoto, Hideaki Kaneto, Takeshi Osonoi, et al.. (2011). Transforming growth factor β1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 94(3). e57–e60. 6 indexed citations
19.
Katakami, Naoto, Hideaki Kaneto, Taka‐aki Matsuoka, et al.. (2010). Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients. Atherosclerosis. 212(2). 534–538. 25 indexed citations
20.
Katakami, Naoto, Munehide Matsuhisa, Hideaki Kaneto, et al.. (2010). Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 89(1). e9–e12. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Cozzolino Breakdown of academic impact, for papers by Hidenori Yoshii Breakdown of academic impact, for papers by Caterina Mammi Breakdown of academic impact, for papers by Muxun Zhang Breakdown of academic impact, for papers by Shojiro Sawada Breakdown of academic impact, for papers by Ya‐Hui Hu Breakdown of academic impact, for papers by Salim Thabet Breakdown of academic impact, for papers by Takuhito Shoji Breakdown of academic impact, for papers by Gang Yuan Breakdown of academic impact, for papers by Brent A. McLean
Rankless by CCL
2026